Mumbai, July 27 -- Shares of Dr. Lal PathLabs rose 4.27% on Friday, 24 July 2026, after the company reported its Q1 FY27 results. With today's gain, the stock has advanced 10.50% over two trading sessions. It has climbed 31.67% over the last three months and 21.19% over the past one year.

The company's consolidated profit after tax increased 27.2% YoY to Rs 170 crore in Q1 FY27. Revenue from operations increased 19.1% YoY to Rs 798 crore in the quarter ended 30 June 2026.

EBITDA increased 28.7% YoY to Rs 247 crore, while the EBITDA margin expanded 230 basis points YoY to 31.0%. Profit before tax stood at Rs 229 crore in Q1 FY27, up 26.3% YoY.

Material consumed increased 17.8% YoY to Rs 152 crore, while employee benefit expenses rose 7....